Top dvm360 articles of 2023: #15
We have compiled a countdown of our top 15 articles in 2023, here is number 15
Image courtesy of Boehringer Ingelheim.
15. FDA approves first oral liquid medication to treat diabetes in cats
By Caitlin McCafferty, Editor
Closing out the top 15, this FDA update reveals Boehringer Ingelheim’s oral liquid medication Senvelgo (velagliflozin oral solution) has received approval as a once-a-day treatment that helps improve glycemic control in cats suffering from diabetes. The drug can be administered by pet parents in their cat’s food or directly in the cat’s mouth.
Click here to read the full article.
Veterinary Heroes: Ann E. Hohenhaus, DVM, DACVIM (Oncology, SAIM)
December 1st 2024A trailblazer in small animal internal medicine, Ann E. Hohenhaus, DVM, DACVIM (Oncology, SAIM), has spent decades advancing the profession through clinical expertise, mentorship, and impactful communication.
Read More
Oral solution approved by the FDA for canine heart failure
November 22nd 2024Vetmedin Solution from Boehringer Ingelheim is indicated for treatment of cases caused by myxomatous mitral valve disease or dilated cardiomyopathy and is the first oral solution approved by the FDA for this use in dogs
Read More
